Qube Research & Technologies (QRT)
NMRD

Qube Research & Technologies (QRT)’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8
Closed -$2 – 5024
2023
Q4 		$2 Hold
8
– – ﹤0.01% 4263
2023
Q3 		$3 Buy
+8
New +$6 ﹤0.01% 4001

Other funds holding NMRD

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NMRD Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q1 2024, closing a stake of 8 shares — an estimated $2 sold.

Qube Research & Technologies (QRT) first reported a position in NMRD in Q3 2023 and held it in 2 quarters. The position peaked at $3 in Q3 2023. 2 funds tracked by Wall St. Rank hold NMRD as of Q1 2024.

  • Qube Research & Technologies (QRT) reported no remaining Nemaura Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 8 Nemaura Medical, Inc. Common Stock shares in Q1 2024, an estimated $2.
  • Qube Research & Technologies (QRT) first reported a position in Nemaura Medical, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Nemaura Medical, Inc. Common Stock position peaked at $3 in Q3 2023.
  • 2 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.